levonorgestrel has been researched along with Cancer of Endometrium in 119 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (4.20) | 18.2507 |
| 2000's | 26 (21.85) | 29.6817 |
| 2010's | 50 (42.02) | 24.3611 |
| 2020's | 38 (31.93) | 2.80 |
| Authors | Studies |
|---|---|
| George, M; Kalantaridou, S; Papadimitriou, S; Paschopoulos, M; Tsonis, O; Zisi, M; Zygouris, D | 1 |
| Du, ZQ; Liang, YQ; Yao, Z; Zhang, X; Zhao, SF; Zhao, XL | 1 |
| Arencibia Sánchez, O; Bataller, Á; Cabrera, S; Corbalán, S; Coronado, P; Domingo, J; Domingo, S; Espinosa, E; Fiol, G; Gil-Ibañez, B; Gil-Moreno, A; Iacoponi, S; Lago, V; Laseca Modrego, M; Marina, T; Martín Salamanca, B; Minig, L; Munmanny, M; Padilla-Iserte, P; Rodriguez, JR; Sala Ferichola, M; Utrilla-Layna, J | 1 |
| Contreras, NA; Fernández-Montolí, ME; Julià, C; Sabadell, J; Verdaguer, P | 1 |
| Buca, D; D'Antonio, F; De Rocco, S; Dessole, M; Fanfani, F; Leombroni, M; Liberati, M; Lucidi, A; Nappi, L; Oronzii, L; Petrillo, M; Scambia, G | 1 |
| Jiang, J; Li, X; Peng, H | 1 |
| Hirata, T; Ikeda, T; Kondo, E; Kubo-Kaneda, M; Maezawa, T; Magawa, S; Nii, M; Tabata, T; Yoshida, K | 1 |
| Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F | 1 |
| Catania, F; Centini, G; Exacoustos, C; Giorgi, M; Labanca, L; Lazzeri, L; Martire, FG; Zupi, E | 1 |
| Liu, Z; Niu, J; Shi, C; Zhao, X | 1 |
| Cao, D; Chen, J; Cheng, N; Peng, P; Shen, K; Wang, J; Yang, J; Yu, M; Zhang, Y; Zhou, H | 1 |
| Chen, X; Guan, J; Liao, J; Shan, W; Shao, W; Xu, Z; Yang, B | 1 |
| Dong, Z; Guo, W; Ma, C; Pan, N; Wei, H; Xiong, G; Zhang, W | 1 |
| Agarwal, R; González, JL; Hong, KM; Klar, M; Mandelbaum, RS; Matsuo, K; Obermair, A; Paulson, RJ; Roman, LD; Violette, CJ; Wright, JD | 1 |
| Caldwell, A; Joseph, S; Landrum, LM; Minalt, N; Peipert, JF; Robertson, SE; Yedlicka, GM | 1 |
| Arencibia Sánchez, O; Emergi Zhrigen, Y; Gil González, Y; Laseca Modrego, M; Martín Martínez, AI; Nieto Naya, MÁ; Ocón Padrón, L; Pérez Matos, C; Pérez Morales, ME; Sánchez Sánchez, V; Santana Suárez, MA | 1 |
| Dore, M; Faya, N; Filoche, S; Henry, C | 1 |
| Ma, C; Pan, N; Wang, Y; Wei, H | 1 |
| Barr, CE; Crosbie, EJ | 2 |
| Farthing, A | 1 |
| Koskas, M; Maumy, L; Peigné, M | 1 |
| Gowri, V; Rawahi, TA; Shikeli, S | 1 |
| Gkegkes, I; Iavazzo, C; Vrachnis, N | 1 |
| Bodurka, DC; Broaddus, RR; Burzawa, JK; Coleman, RL; Fellman, B; Fleming, ND; Lu, KH; Milbourne, AM; Nick, AM; Pal, N; Ramondetta, LM; Schmeler, KM; Soliman, PT; Sun, CC; Urbauer, DL; Westin, SN; Woodall, ML; Yates, MS; Yuan, Y | 1 |
| Du, H; Jiang, J; Peng, H | 1 |
| Christianson, MS; Cordeiro Mitchell, CN; Garbose, RA; Gornet, ME; Hunkler, KF; Maher, JY; Whiting-Collins, LJ | 1 |
| He, Y; Wang, J; Wang, Y; Zhou, R | 1 |
| Bifulco, G; De Franciscis, P; Di Spiezio Sardo, A; Gencarelli, A; Insabato, L; Micheli, M; Miranda, S; Raffone, A; Travaglino, A; Zullo, F; Zullo, FM | 1 |
| Bosco, M; Franchi, MP; Garzon, S; Mariani, A; Student, V; Uccella, S; Zorzato, PC | 1 |
| Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
| Hickey, M; Romero, SA; Su, HI; Young, K | 1 |
| Andreeva, YY; Krasnopolskaya, KV; Nosov, VB; Novikova, EG; Novikova, OV; Panov, VA; Shevchuk, AS | 1 |
| Bernard, L; Ferguson, SE; Kwon, JS; Pina, A; Reade, CJ; Simpson, AN; Sinasac, S | 1 |
| Alizart, M; Armes, JE; Chen, C; Chetty, N; Cummings, M; Eva, L; Garrett, A; Gebski, V; Hoet, G; Janda, M; Land, R; Leung, Y; McNally, O; Nicklin, JL; Obermair, A; Oehler, MK; Perrin, LC; Robledo, KP; Sowden, K; Sykes, P; Tang, A; Tristram, A; Walker, G | 1 |
| Contreras-Perez, NA; Fernandez-Montoli, ME; Sabadell, J | 1 |
| Chae, SH; Han, ES; Kang, SB; Kim, TJ; Lee, JY; Lee, SJ; Shim, SH; So, KA | 1 |
| Collins, D; Hanna, L; Steshenko, A | 1 |
| Bae, HS; Hwang, JY; Jung, YW; Kim, DH; Kim, MK; Kim, ML; Seong, SJ; Shin, E; Yun, BS | 1 |
| Baker, WD; Duska, LR; Gehrig, PA; Mills, AM; Pierce, SR | 1 |
| Cao, D; Lang, J; Shen, K; Yang, J; Zhou, H | 1 |
| Choi, YM; Kim, H; Kim, SH; Kim, SW; Ku, SY; Suh, CS | 1 |
| Balakrishnan, N; Bodurka, DC; Broaddus, RR; Lu, KH; Meyer, LA; Milbourne, A; Pal, N; Ramirez, PT; Ramondetta, L; Schmeler, KM; Soliman, PT; Urbauer, DL; Westin, SN | 1 |
| Aarflot, M; Braaten, T; Bøvelstad, HM; Jareid, M; Lund, E; Thalabard, JC | 1 |
| Dundr, P; Fanta, M; Koliba, P; Kuzel, D; Mara, M; Zizka, Z | 1 |
| Bae, DS; Kang, SB; Kim, JW; Kim, MK; Kim, S; Lee, TS; Lim, MC; Nam, JH; Paek, J; Seong, SJ | 1 |
| Chen, X | 1 |
| Bogani, G; Chiappa, V; Ditto, A; Dondi, G; Evangelista, MT; Ferrero, S; Leone Roberti Maggiore, U; Liberale, V; Martinelli, F; Raspagliesi, F | 1 |
| Casadio, P; Guasina, F; Magnarelli, G; Morra, C; Paradisi, R; Seracchioli, R; Talamo, MR | 1 |
| Jun, HS; Kim, MK; Kim, ML; Kim, YS; Lee, YH; Seong, SJ; Song, T; Yoon, BS | 1 |
| Schorge, JO | 1 |
| Jun, HS; Kim, MK; Kim, ML; Lee, GH; Lee, YH; Seong, SJ; Song, T; Yoon, BS | 1 |
| Cade, TJ; Neesham, D; Quinn, MA; Rome, RM | 2 |
| Caputo, TA; Gupta, D; Holcomb, KM; Kligman, I; Kudesia, R; Rosenwaks, Z; Singer, T | 1 |
| La Ferrera, N; Prota, G; Russo, V; Trapasso, S | 1 |
| Armes, J; Brennan, D; Gebski, V; Hawkes, AL; Janda, M; Obermair, A; Quinn, M | 1 |
| Grénman, S; Hurskainen, R; Mäenpää, J; Paavonen, J; Pukkala, E; Soini, T | 1 |
| Andreeva, IuIu; Danilova, NV; Lozovaia, IuA; Novikova, EG; Novikova, OV; Podtetenev, DV; Pronin, SM; Rubtsova, NA; Vostrov, AN | 1 |
| Benjamin, E; Conway, GS; McGregor, D; Olaitan, A; Saridogan, E; Swamy, A | 1 |
| Fu, Y; Zhuang, Z | 1 |
| Jóźwik, M; Modzelewska, B; Niewińska, M | 1 |
| Chin, J; Dominick, S; Hickey, M; Su, HI | 1 |
| Cholakian, D; Fader, AN; Gehrig, PA; Hacker, K; Tanner, EJ | 1 |
| Cetinkaya, N; Erkaya, S; Gungor, T; Yalcin, H; Zergeroglu, S | 1 |
| Chino, J; Dottino, JA; Hasselblad, V; Havrilesky, LJ; Myers, ER; Secord, AA | 1 |
| Cascella, M; Falcone, F; Gallo, MS; Granata, V; Greggi, S; Laurelli, G; Losito, S; Scala, F | 1 |
| Di Napoli, M; Falcone, F; Granata, V; Greggi, S; Laurelli, G; Losito, S | 1 |
| Bae, HS; Jung, YW; Kim, DH; Kim, M; Kim, MK; Seong, SJ; Shim, JY; Yun, BS | 1 |
| Hanna, LS; van der Meer, AC | 1 |
| Briggs, P; Thomas, M | 1 |
| Jaeger, R; Moe, BT; Orbo, A; Sager, G; Vereide, AB | 1 |
| Amant, F; Moerman, P; Van Eygen, K; Vandenput, I; Vergote, I | 1 |
| Chin, J; Hickey, M; Konje, JC | 1 |
| Bocciolone, L; Boveri, S; Casadio, C; Franchi, D; Minig, L; Sideri, M | 1 |
| Del Giudice, M; Di Vagno, G; Greggi, S; Laurelli, G; Losito, S; Scaffa, C | 1 |
| Beiner, M; Ben-Baruch, G; Ferenczy, A; Friedman, E; Gotlieb, WH; Korach, J; Meirow, D; Perri, T | 1 |
| Jung, YW; Kim, JW; Seong, SJ | 1 |
| Park, H; Seong, SJ; Yoon, BS | 1 |
| Chung, HH; Kang, SB; Kim, JW; Kim, MK; Park, H; Seong, SJ; Yoon, BS | 1 |
| Huang, XH; Wang, X | 1 |
| Haoula, ZJ; Powell, MC; Walker, KF | 1 |
| Holland, C; Wan, YL | 1 |
| Bouchard, P | 1 |
| Leslie, KK; Thiel, KW; Yang, S | 1 |
| Broaddus, RR; Brown, AJ; Schmeler, K; Westin, SN | 1 |
| Ionouchene, SV; Pashov, AI; Tskhay, VB | 1 |
| Atkins, KA; Hanley, KZ; Mentrikoski, MJ; Shah, AA | 1 |
| Hong, SR; Kim, JW; Kim, MK; Lee, TS; Nam, BH; Seong, SJ; Suh, KS | 1 |
| D'Alessandro, P; Di Cello, A; Mocciaro, R; Morelli, M; Venturella, R; Zullo, F | 1 |
| Gelli, MC; La Sala, GB; Mandato, VD; Nucera, G; Palomba, S | 1 |
| Georgiou, M; Hyatt, D; Jones, K; Spencer, T; Thomas, H | 1 |
| Nwosu, EC; Sinha, A | 1 |
| Bahamondes, L; de Andrade, KC; Leon-Martins, O; Petta, CA; Ribeiro-Huguet, P | 1 |
| Espié, M | 1 |
| Archer, DF; Leslie, S; Mirkin, S; Navarro, FJ | 1 |
| Butler-Manuel, S; Giannopoulos, T; Tailor, A | 1 |
| Johnson, MJ; Morgan, KW | 1 |
| Kaino, T; Sager, G; Vereide, AB; Ørbo, A | 1 |
| Dhar, KK; Koslowski, M; NeedhiRajan, T; Woolas, RP | 1 |
| Bradley, LD | 1 |
| Clark, TJ; Gupta, JK; Neelakantan, D | 1 |
| Gupta, JK; Sinha, D; Varma, R | 1 |
| Husemeyer, RP; Ndumbe, FM | 1 |
| Boutet, G | 1 |
| Critchley, HO; Guttinger, A | 1 |
| Chan, SS; Kwan, WH; Ng, DP; Tam, WH; Wong, AW; Yeo, W; Yu, MM; Yuen, PM | 1 |
| Kresowik, J; Ryan, GL; Van Voorhis, BJ | 1 |
| Burnog, T; Hortíková, Z | 1 |
| Bargelli, G; Moncini, D; Scarselli, B; Scarselli, G; Taddei, GL | 1 |
| Bennink, HC; Mascarenhas, L; Newton, J; van Beek, A | 1 |
| Dwarte, D; Fraser, IS; Hickey, M | 1 |
| Abulafia, O; Sherer, DM | 1 |
| Brechin, S; Cameron, ST; Critchley, HO; Paterson, AM; Williams, AR | 1 |
| Rutanen, EM | 1 |
| Cohen, I | 1 |
| Friese, K; Gerber, B; Krause, A; Müller, H; Reimer, T | 1 |
| Grimes, DA; Hubacher, D | 1 |
30 review(s) available for levonorgestrel and Cancer of Endometrium
| Article | Year |
|---|---|
Uterine sparing management in patients with endometrial cancer: a narrative literature review.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Levonorgestrel; Pregnancy; Uterus | 2022 |
Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Levonorgestrel; Progestins | 2022 |
Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
Topics: Abortion, Spontaneous; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Precancerous Conditions; Pregnancy; Pregnancy Outcome | 2022 |
Endometrial Cancer Following Levonorgestrel-Releasing Intrauterine System Insertion in Young Women with Atypical Hyperplasia: Two Case Reports and Literature Review.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hyperplasia; Intrauterine Devices, Medicated; Levonorgestrel; Progestins; Tumor Suppressor Protein p53 | 2022 |
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin | 2022 |
Unilateral hydroureteronephrosis after introduction of a levonorgestrel-releasing intrauterine system: a case report and literature review.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2023 |
Levonorgestrel-releasing intrauterine system-based therapies for early-stage endometrial cancer: a systematic review and meta-analysis.
Topics: Carcinoma, Endometrioid; Child, Preschool; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy | 2023 |
Association between intrauterine device use and endometrial, cervical, and ovarian cancer: an expert review.
Topics: Cervix Uteri; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Ovarian Neoplasms; Uterine Cervical Neoplasms | 2023 |
Role of hysteroscopy during conservative management of atypical endometrial hyperplasia and early-stage endometrial cancer in patients who desire pregnancy.
Topics: Conservative Treatment; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy | 2022 |
Fertility-sparing management for endometrial cancer: review of the literature.
Topics: Administration, Oral; Drug Carriers; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Levonorgestrel; Metformin; Progestins | 2021 |
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen; Uterine Hemorrhage; Uterus | 2020 |
Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis.
Topics: Breast Neoplasms; Chi-Square Distribution; Endometrial Neoplasms; Endometrium; Estrogen Antagonists; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Odds Ratio; Polyps; Risk Factors; Tamoxifen; Treatment Outcome | 2014 |
[Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women].
Topics: Adenocarcinoma; Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Evidence-Based Medicine; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2015 |
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen | 2015 |
Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Levonorgestrel; Prognosis; Treatment Failure | 2009 |
Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Polyps; Randomized Controlled Trials as Topic; Tamoxifen | 2009 |
[Progress on surgical treatment and prevention of recurrence in endometrial polyps].
Topics: Age Factors; Dilatation and Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Hysterectomy; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Polyps; Progestins; Prognosis; Secondary Prevention; Severity of Illness Index | 2011 |
The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review.
Topics: Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Risk Factors; Treatment Outcome | 2011 |
Current and future medical treatments for menometrorrhagia during the premenopause.
Topics: Adolescent; Adult; Contraceptives, Oral; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Levonorgestrel; Menorrhagia; Metrorrhagia; Mifepristone; Norpregnadienes; Polyps; Premenopause; Progestins; Randomized Controlled Trials as Topic; Receptors, Progesterone; Uterine Neoplasms | 2011 |
Endometrial polyp and the levonorgestrel intrauterine system--a case report and literature review.
Topics: Adenocarcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged; Polyps; Progesterone Congeners | 2002 |
Intrauterine contraception benefits extend beyond birth control.
Topics: Adolescent; Adult; Copper; Cost-Benefit Analysis; Endometrial Neoplasms; Estrogen Replacement Therapy; Female; Global Health; Humans; Intrauterine Devices; Levonorgestrel; Uterine Hemorrhage | 2005 |
Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Drug Administration Routes; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Uterus | 2005 |
Abnormal uterine bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Catheter Ablation; Contraceptives, Oral; Danazol; Dilatation and Curettage; Embolization, Therapeutic; Endometrial Hyperplasia; Endometrial Neoplasms; Endosonography; Estrogen Antagonists; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Hysteroscopy; Levonorgestrel; Magnetic Resonance Imaging; Perimenopause; Puberty; Risk Factors; Treatment Outcome; Uterine Hemorrhage; von Willebrand Diseases | 2005 |
Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
Topics: Delayed-Action Preparations; Dysmenorrhea; Endometrial Hyperplasia; Endometrial Neoplasms; Endometriosis; Estrogen Replacement Therapy; Female; Humans; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Menorrhagia | 2006 |
[Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Evidence-Based Medicine; Female; France; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Tamoxifen | 2006 |
Endometrial effects of intrauterine levonorgestrel.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Matrix Metalloproteinases; Metrorrhagia; Receptors, Steroid | 2007 |
Precancerous lesions of the endometrium and medical treatment.
Topics: Drug Monitoring; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Postmenopause; Precancerous Conditions; Premenopause; Progesterone Congeners; Progestins | 1997 |
Angiogenesis of the endometrium.
Topics: Carcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Endometriosis; Endometrium; Female; Humans; Leiomyoma; Levonorgestrel; Neovascularization, Physiologic | 1999 |
Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Female; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Intrauterine Devices, Medicated; Levonorgestrel; Receptor, IGF Type 1; Receptor, IGF Type 2; RNA, Messenger | 2000 |
Noncontraceptive health benefits of intrauterine devices: a systematic review.
Topics: Endometrial Neoplasms; Female; Genital Diseases, Female; Hormone Replacement Therapy; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Progesterone Congeners | 2002 |
16 trial(s) available for levonorgestrel and Cancer of Endometrium
| Article | Year |
|---|---|
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial pr
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Metformin; Obesity; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic | 2022 |
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (Clini
Topics: Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Prospective Studies | 2023 |
Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Aldehyde Dehydrogenase 1 Family; Biomarkers; Biomarkers, Tumor; Body Mass Index; Carcinoma, Endometrioid; Contraceptive Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gene Expression; Humans; Intercellular Signaling Peptides and Proteins; Intrauterine Devices, Medicated; Ki-67 Antigen; Levonorgestrel; Membrane Proteins; Middle Aged; Neoplasm Grading; Neoplasm Staging; Quality of Life; Receptors, Cell Surface; Retinal Dehydrogenase; Treatment Outcome; Wnt Signaling Pathway; Young Adult | 2021 |
Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial.
Topics: Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metformin; Middle Aged; Neoplasm Staging; Weight Loss; Weight Reduction Programs | 2021 |
Six months response rate of combined oral medroxyprogesterone/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study.
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Biopsy, Needle; Carcinoma, Endometrioid; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Prospective Studies | 2019 |
Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial.
Topics: Adenocarcinoma; Biomarkers, Tumor; Diet; Endometrial Neoplasms; Exercise; Female; Humans; Intrauterine Devices; Levonorgestrel; Metformin; Neoplasm Staging; Obesity; Prospective Studies; Research Design; Weight Loss | 2014 |
[Hormone therapy alone for pre-cancerous conditions and early endometrial cancer: pros and cons].
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Goserelin; Humans; Levonorgestrel; Neoplasm Recurrence, Local; Precancerous Conditions; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Rate; Treatment Outcome | 2014 |
Long-Term Oncologic and Reproductive Outcomes in Young Women With Early Endometrial Cancer Conservatively Treated: A Prospective Study and Literature Update.
Topics: Adult; Endometrial Neoplasms; Female; Fertility; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Organ Sparing Treatments; Pregnancy; Prospective Studies | 2016 |
Conservative treatment of early endometrial cancer: preliminary results of a pilot study.
Topics: Adult; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Endometrial Neoplasms; Female; Fertility; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Staging; Pilot Projects; Prospective Studies | 2011 |
Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women: pilot study.
Topics: Adult; Age Factors; Algorithms; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Endometrial Neoplasms; Feasibility Studies; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Pilot Projects | 2011 |
Levonorgestrel intra-uterine system as a treatment option for complex endometrial hyperplasia.
Topics: Aged; Anticarcinogenic Agents; Biopsy; Drug Delivery Systems; Drug Monitoring; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Middle Aged; Progestins; Remission Induction | 2011 |
The combined GnRH-agonist and intrauterine levonorgestrel-releasing system treatment of complicated atypical hyperplasia and endometrial cancer: a pilot study.
Topics: Adenocarcinoma; Administration, Intravaginal; Adult; Antineoplastic Agents, Hormonal; Delayed-Action Preparations; Drug Delivery Systems; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Injections, Intramuscular; Leuprolide; Levonorgestrel; Neoplasm Staging; Organ Sparing Treatments; Pilot Projects; Progestins; Young Adult | 2012 |
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.
Topics: Administration, Oral; Adult; Aged; Apoptosis; bcl-2-Associated X Protein; Biopsy; Dose-Response Relationship, Drug; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone; Middle Aged; Precancerous Conditions; Progestins; Proto-Oncogene Proteins c-bcl-2 | 2005 |
A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Polyps; Postmenopause; Premenopause; Tamoxifen; Uterine Diseases | 2007 |
[Klimonorm and precanceroses of the endometrium].
Topics: Climacteric; Cloprostenol; Drug Combinations; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Precancerous Conditions; Prospective Studies | 1994 |
A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.
Topics: Adolescent; Adult; Cervix Uteri; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometrial Neoplasms; Endometrium; Female; Humans; Hyperplasia; Levonorgestrel; Prospective Studies; Risk Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears; Vinyl Compounds | 1998 |
73 other study(ies) available for levonorgestrel and Cancer of Endometrium
| Article | Year |
|---|---|
Fertility-preserving treatment in patients with early-stage endometrial cancer: A protocol for systematic review and meta-analysis.
Topics: Contraceptive Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Meta-Analysis as Topic; Pregnancy; Progestins; Systematic Reviews as Topic | 2021 |
Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG).
Topics: Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies; Spain | 2022 |
Safety and efficacy of levonorgestrel-releasing intrauterine device in the treatment of atypical endometrial hyperplasia and early endometrial cancer.
Topics: Adult; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2022 |
Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia.
Topics: Aromatase Inhibitors; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Letrozole; Levonorgestrel; Male; Pregnancy; Progestins; Retrospective Studies | 2022 |
The potential role of GLP-1 receptor agonist targeting in fertility-sparing treatment in obese patients with endometrial malignant pathology: a call for research.
Topics: Adult; Diabetes Mellitus, Type 2; Endometrial Neoplasms; Female; Fertility Preservation; Glucagon-Like Peptide-1 Receptor; Humans; Levonorgestrel; Obesity; Polycystic Ovary Syndrome; Pregnancy; Progestins | 2023 |
Transcriptomic identification of differentially expressed genes in Levonorgestrel resistant endometrial cancer cell lines.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Female; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Levonorgestrel; Protein Processing, Post-Translational; Transcriptome | 2023 |
Segmented in vitro fertilization and frozen embryo transfer in levonorgestrel-releasing intrauterine device treated patients with endometrial cancer.
Topics: Adult; Carcinoma, Endometrioid; Embryo Transfer; Endometrial Neoplasms; Female; Fertilization in Vitro; Humans; Intrauterine Devices; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Rate; Retrospective Studies | 2023 |
The Mirena coil is a suitable treatment of early-stage endometrial cancer in obese women: FOR: Careful selection and monitoring is key.
Topics: Adult; Antineoplastic Agents, Hormonal; Contraceptive Agents, Female; Contraindications, Procedure; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Monitoring, Physiologic; Obesity; Patient Selection; Progesterone Congeners | 2020 |
The Mirena coil is a suitable treatment of early-stage endometrial cancer in obese women: AGAINST: Please follow the manufacturer's advice.
Topics: Adult; Antineoplastic Agents, Hormonal; Contraceptive Agents, Female; Contraindications, Drug; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Neoplasm Staging; Obesity; Pamphlets; Patient Education as Topic; Progesterone Congeners | 2020 |
A survey of French gynecologists' knowledge and attitudes toward conservative treatment for fertility preservation in young patients with endometrial cancer.
Topics: Adenocarcinoma; Adult; Attitude of Health Personnel; Conservative Treatment; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; France; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Gynecology; Health Knowledge, Attitudes, Practice; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Male; Middle Aged; Patient Education as Topic; Pregnancy; Progestins; Reproductive Medicine; Surveys and Questionnaires | 2020 |
Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience.
Topics: Adult; Antineoplastic Agents, Hormonal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Treatment Outcome; Young Adult | 2020 |
Authors' reply re: Mirena Coil is a suitable treatment of early-stage endometrial cancer in obese women: FOR or AGAINST?: Treat the patient, not the disease.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Obesity | 2020 |
Re: Mirena Coil is a suitable treatment of early stage endometrial cancer in obese women: FOR or AGAINST?
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Obesity | 2020 |
Advanced endometrial cancer following the insertion of the levonorgestrel-releasing intrauterine system in a 34-year-old woman: A case report.
Topics: Adult; Biopsy; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Grading; Neoplasm Staging; Treatment Outcome | 2020 |
Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae.
Topics: Adult; Carcinoma in Situ; Conservative Treatment; Contraceptive Agents, Female; Dilatation and Curettage; Endometrial Neoplasms; Female; Gynatresia; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Risk | 2021 |
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Retreatment; Retrospective Studies; Young Adult | 2020 |
Predictive Accuracy of Progesterone Receptor B in Young Women with Atypical Endometrial Hyperplasia and Early Endometrial Cancer Treated with Hysteroscopic Resection plus LNG-IUD Insertion.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Receptors, Progesterone; Retrospective Studies | 2021 |
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |
Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Middle Aged; Pregnancy; Prospective Studies; Treatment Outcome; Young Adult | 2021 |
The levonorgestrel intrauterine system for prevention of endometrial cancer in women with obesity: A cost-effectiveness study.
Topics: Age Factors; Aged; Aged, 80 and over; Canada; Contraceptive Agents, Hormonal; Cost-Benefit Analysis; Endometrial Neoplasms; Female; Health Care Costs; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Markov Chains; Middle Aged; Models, Economic; Obesity; Retrospective Studies; Risk Factors | 2021 |
Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol.
Topics: Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Review Literature as Topic; Systematic Reviews as Topic | 2021 |
Optimal duration of fertility-sparing hormonal treatment for early-stage endometrioid endometrial cancer.
Topics: Adult; Carcinoma, Endometrioid; Drug Administration Schedule; Electronic Health Records; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Levonorgestrel; Republic of Korea; Retrospective Studies; Young Adult | 2021 |
Development of endometrial cancer after long-term usage of the levonorgestrel-releasing intrauterine system.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Uterine Hemorrhage | 2021 |
Combined Oral Medroxyprogesterone/Levonorgestrel-Intrauterine System Treatment for Women With Grade 2 Stage IA Endometrial Cancer.
Topics: Administration, Oral; Adult; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Neoplasm Grading; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Retrospective Studies | 2017 |
Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women.
Topics: Aged; Aged, 80 and over; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices; Levonorgestrel; Middle Aged; Neoplasm Grading; Postmenopause; Receptors, Progesterone; Retrospective Studies | 2017 |
Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices, Medicated; Letrozole; Levonorgestrel; Nitriles; Retrospective Studies; Triazoles; Young Adult | 2017 |
A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Conservative Treatment; Cryopreservation; Embryo Transfer; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Letrozole; Levonorgestrel; Live Birth; Megestrol Acetate; Neoplasm Recurrence, Local; Nitriles; Pregnancy; Pregnancy Outcome; Triazoles | 2018 |
Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device.
Topics: Adult; Biopsy, Needle; Cancer Care Facilities; Cohort Studies; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Precancerous Conditions; Retrospective Studies; Risk Assessment; Texas; Young Adult | 2018 |
Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Neoplasms, Glandular and Epithelial; Norway; Ovarian Neoplasms; Prospective Studies; Surveys and Questionnaires | 2018 |
Malignant endometrial polyp in woman with the levonorgestrel intrauterine system - a case report.
Topics: Asymptomatic Diseases; Biopsy; Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Polyps; Ultrasonography | 2019 |
The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia.
Topics: Conservative Treatment; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Humans; Hyperplasia; Levonorgestrel; Retrospective Studies | 2019 |
Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.
Topics: Adult; Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Retrospective Studies | 2019 |
Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Longitudinal Studies; Middle Aged; Pilot Projects; Prospective Studies; Treatment Outcome | 2019 |
Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Prospective Studies; Remission Induction; Treatment Outcome | 2013 |
Nonsurgical treatment of endometrial hyperplasia: is the road less traveled the one we should be taking more?
Topics: Carcinoma, Endometrioid; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Minimally Invasive Surgical Procedures; Obesity; Progestins | 2013 |
Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Staging; Organ Sparing Treatments; Progestins; Prospective Studies | 2013 |
Long-term outcomes after progestogen treatment for early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Medroxyprogesterone Acetate; Pregnancy; Progestins; Time Factors; Young Adult | 2013 |
Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pregnancy; Pregnancy Outcome; Progesterone; Retrospective Studies; Treatment Outcome | 2014 |
[The levonogestrel-releasing intrauterine device and endometrial cancer: a potential opportunity for young women].
Topics: Adult; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2014 |
Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.
Topics: Adenocarcinoma; Adult; Breast Neoplasms; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Finland; Follow-Up Studies; Humans; Incidence; Intrauterine Devices, Medicated; Levonorgestrel; Lung Neoplasms; Menorrhagia; Middle Aged; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Registries | 2014 |
Endometrial cancer in a woman with 46,XY pure gonadal dysgenesis.
Topics: Adult; Drug Combinations; Endometrial Neoplasms; Ethinyl Estradiol; Female; Gonadal Dysgenesis, 46,XY; Hormone Replacement Therapy; Hormones; Humans; Incidental Findings; Levonorgestrel; Ovariectomy; Treatment Outcome | 2015 |
Effect of oral versus intrauterine progestins on weight in women undergoing fertility preserving therapy for complex atypical hyperplasia or endometrial cancer.
Topics: Adult; Body Weight; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progestins; Young Adult | 2016 |
Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Incidental Findings; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Retrospective Studies; Turkey | 2016 |
Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis.
Topics: Body Mass Index; Contraceptive Agents, Female; Cost-Benefit Analysis; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Models, Economic; Monte Carlo Method; Obesity | 2016 |
Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Hysteroscopy; Intrauterine Devices; Levonorgestrel; Megestrol Acetate; Pregnancy; Progestins; Prospective Studies; Young Adult | 2017 |
Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Biopsy, Needle; Dilatation and Curettage; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Prospective Studies; Reproducibility of Results | 2017 |
Development of endometrioid adenocarcinoma despite Levonorgestrel-releasing intrauterine system: a case report with discussion and review of the RCOG/BSGE Guideline on the Management of Endometrial Hyperplasia.
Topics: Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy, Vaginal; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Obesity, Morbid; Ovariectomy; Practice Guidelines as Topic; Risk Factors; Treatment Outcome | 2017 |
A case of endometrial carcinoma in a long-term Levonorgestrel Intrauterine System (LNG 52 mg-IUS) user.
Topics: Carcinoma, Endometrioid; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Uterine Hemorrhage | 2017 |
Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Drug Synergism; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Medroxyprogesterone; Mifepristone; Progesterone; Progestins; Receptors, Progesterone | 2009 |
Progestogen treatment options for early endometrial cancer.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Curettage; Endometrial Neoplasms; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Neoplasm, Residual; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
Topics: Adult; Antineoplastic Agents, Hormonal; Drug Delivery Systems; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Infertility; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Ovarian Neoplasms; Pregnancy; Prospective Studies; Recurrence; Treatment Outcome; Young Adult | 2011 |
Prolonged conservative treatment of endometrial cancer patients: more than 1 pregnancy can be achieved.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2011 |
Should diagnostic laparoscopy be conducted before hormonal treatment in early-stage endometrial cancer?
Topics: Antineoplastic Agents, Hormonal; Clinical Trials as Topic; Drug Therapy, Combination; Endometrial Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Levonorgestrel; Neoplasms, Multiple Primary; Ovarian Neoplasms | 2011 |
The effect of operative hysteroscopy conducted before progestin treatment in early stage endometrial cancer from the view of fertility.
Topics: Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Megestrol Acetate | 2011 |
Endometrial cancer: potential treatment and prevention with progestin-containing intrauterine devices.
Topics: Adenocarcinoma; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2012 |
Progestin intrauterine device in an adolescent with grade 2 endometrial cancer.
Topics: Adenocarcinoma; Adolescent; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Organ Sparing Treatments | 2012 |
Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Levonorgestrel; Megestrol Acetate; Menopause; Middle Aged; Prognosis; Treatment Failure; Young Adult | 2012 |
Treatment with medroxyprogesterone acetate plus levonorgestrel-releasing intrauterine system for early-stage endometrial cancer in young women: single-arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2009).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Prospective Studies; Republic of Korea | 2012 |
Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
Topics: Administration, Intravaginal; Aged; Body Mass Index; Cell Proliferation; Drug Delivery Systems; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Follow-Up Studies; Humans; Italy; Levonorgestrel; Middle Aged; Obesity; Overweight; Postmenopause; Retrospective Studies; Risk; Secondary Prevention; Uterine Hemorrhage | 2013 |
Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Contraceptive Agents, Female; Delayed-Action Preparations; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Intrauterine Devices, Medicated; Leuprolide; Levonorgestrel; Neoplasm Staging; Pregnancy; Remission Induction; Term Birth | 2013 |
Endometrial adenocarcinoma following the insertion of a Mirena IUCD.
Topics: Adenocarcinoma; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Middle Aged | 2002 |
Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Delayed-Action Preparations; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Levonorgestrel; Middle Aged; Progesterone Congeners; Treatment Outcome | 2003 |
[Tamoxifen, endometrial cancer and levonorgestrel intra-uterine device].
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Metrorrhagia; Tamoxifen; Treatment Outcome | 2003 |
Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Protein Isoforms; Receptors, Progesterone; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2004 |
Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma.
Topics: Administration, Oral; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Intrauterine Devices; Levonorgestrel; Medroxyprogesterone Acetate | 2004 |
The management of endometrial hyperplasia: an evaluation of current practice.
Topics: Aged; Aged, 80 and over; Biopsy; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Levonorgestrel; Menorrhagia; Middle Aged; Remission Induction; Retrospective Studies; Treatment Outcome; Uterine Hemorrhage | 2006 |
ACOG committee opinion. No. 337: Noncontraceptive uses of the levonorgestrel intrauterine system.
Topics: Contraceptive Agents, Female; Endometrial Neoplasms; Endometrium; Female; Humans; Hyperplasia; Intrauterine Devices; Levonorgestrel; Menorrhagia; Selective Estrogen Receptor Modulators; Tamoxifen | 2006 |
Endometrial adenocarcinoma in association with a levonorgestrel-releasing intrauterine system (Mirena).
Topics: Adenocarcinoma; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged | 2006 |
Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.
Topics: Adenocarcinoma; Adult; Contraceptive Agents, Female; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Treatment Failure | 2008 |
Precise measurements of intrauterine vascular structures at hysteroscopy in menorrhagia and during Norplant use.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Implants; Ecchymosis; Endometrial Neoplasms; Endometrium; Female; Humans; Hysteroscopy; Levonorgestrel; Menorrhagia; Polyps; Purpura; Sensitivity and Specificity; Uterus | 1998 |
Intrauterine polyps--a cause of unscheduled bleeding in women using the levonorgestrel intrauterine system: case report.
Topics: Adult; Aged; Contraceptive Agents, Female; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Polyps; Uterine Hemorrhage; Uterine Neoplasms | 2000 |
Levonorgestrel-releasing intrauterine devices.
Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Postmenopause; Progesterone Congeners; Tamoxifen | 2001 |
Levonorgestrel-releasing intrauterine devices.
Topics: Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Endometrial Neoplasms; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Progesterone Congeners; Tamoxifen | 2001 |